Webcast/CME - Hepatitis B Treatment: Current Best Practices How to Avoid Resistance

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Hepatitis Other

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Hepatitis Other

	HBV-HIV Co-infection
	HBV in Pregnancy
	Debate: Monotherapy vs. Multiple Drug Therapy as the Wave of the Future for HBV Infection
	Understanding Cultural Barriers

Recent news - Hepatitis Other

	Extending PEG-IFN Alfa-2a Therapy in Patients With Chronic HBV Can Lead to HBeAg Seroconversion, HBsAg Clearance: Presented at AASLD - (DGDispatch)
	Patients Previously Treated With Adefovir Can Achieve Complete Viral Suppression When Switched to Entecavir: Presented at AASLD - (DGDispatch)
	Lamivudine, Entecavir Both Improved Prognosis in Hepatitis B-Related Acute-on-Chronic Liver Failure: Presented at AASLD - (DGDispatch)
	Adefovir Plus Lamivudine Is Effective in Patients With Lamivudine-Resistance Chronic Hepatitis B: Presented at AASLD - (DGDispatch)
	Telbivudine Safe and Effective in Suppressing Hepatitis B Over Very Long Term: Presented at AASLD - (DGDispatch)

Recent cases - Hepatitis Other

	Primary Biliary Cirrhosis-Autoimmune Hepatitis Overlap Syndrome Concomitant with Systemic Sclerosis, Immune Thrombocytopenic Purpura
	A Familial Case of Autoimmune Hepatitis
	A 35-Year-Old Asian Man with Jaundice and Markedly High Aminotransferase Levels
	Acute Hepatitis A Virus Infection Presenting with Multiorgan Dysfunction: A Case Report
	Ceftriaxone-Induced Toxic Hepatitis

personal edition > hepatitis other > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Hepatitis B Treatment: Current Best Practices How to Avoid Resistance

Presented by:	The Cleveland Clinic Foundation Center for Continuing Education
Lecturer	William Carey, MD, Robert Gish, MD, Pierre Gholam, MD, Morris Sherman, MB BCh, PhD and Tram Tran, MD
Approximate duration:	30 mins.
Summary points:	This audiovisual presentation discusses the treatment options available to minimise HBV resistance and explains the possible consequences of viral resistance in patients with HBV.
Accreditation:	The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s). Expiration Date: January 15, 2011.
Other:

Additional Information